Companies / BOC Sciences / Oregovomab
BOC Sciences

Oregovomab | BOC Sciences

Oregovomab is a murine monoclonal antibody directed against CA125 antigen. Oregovomab has been studied as a complementary treatment for ovarian cancer.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.